Carnegie Capital Asset Management, LLC Quanterix Corp Transaction History

Carnegie Capital Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 09, 2020	SELL	$19.21 - $28.53 $618,562 - $918,666	-32,200 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$11.17 - $28.72 $344,817 - $886,586	-30,870 Reduced 48.95%	32,200 $592,000
Q4 2019 Feb 13, 2020	SELL	$19.29 - $25.52 $81,596 - $107,949	-4,230 Reduced 6.29%	63,070 $1.49 Million
Q3 2019 Nov 20, 2019	BUY	$21.72 - $35.38 $918,756 - $1.5 Million	42,300 Added 169.2%	67,300 $1.48 Million
Q2 2019 Jul 24, 2019	BUY	$20.59 - $35.2 $514,750 - $880,000	25,000 New	25,000 $845,000

155

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $436M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.